Arrowhead Pharmaceuticals Inc. buy JPMorgan Chase & Co.
Start price
20:30
/
50%
€64.96
Target price
17.07.27
€83.05
Performance (%)
0.00%
Price
22:25
€64.96
Summary
This prediction is currently active. JPMorgan_Chase___Co_'s BUY prediction for Arrowhead Pharmaceuticals Inc. is currently unchanged. This prediction currently runs until 17.07.27. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Arrowhead Pharmaceuticals Inc. | 0.00% |
| iShares Core DAX® | -1.087% |
| iShares Nasdaq 100 | -2.463% |
| iShares Nikkei 225® | -5.371% |
| iShares S&P 500 | -0.197% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals (ARWR) had its price target raised by JPMorgan Chase & Co. from $88.00 to $95.00. They now have an "overweight" rating on the stock.
Ratings data for ARWR provided by MarketBeat